# Prospective Cohort for Adult Hemophagocytosis

> **NCT03117010** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 81 (estimated)

## Conditions studied

- Hemophagocytic Lymphohistiocytoses

## Interventions

- **DRUG:** Steroids
- **DRUG:** Etoposide

## Key facts

- **NCT ID:** NCT03117010
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03117010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03117010, "Prospective Cohort for Adult Hemophagocytosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03117010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*